Levetiracetam Heumann

Levetiracetam, the active ingredient in Levetiracetam Heumann, is an antiepileptic presented as an oral dosage form for oral use. It treats epilepsy, including partial seizures and generalized tonic‑clonic seizures, in both adult and pediatric patients.

GNH USA supplies Levetiracetam Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to control seizure activity across several epilepsy syndromes.

Epilepsy: reduces the frequency and severity of seizures in patients with various epilepsy types. Partial seizures: provides effective control of focal onset seizures, with or without secondary generalization. Generalized tonic‑clonic seizures: helps prevent the occurrence of bilateral convulsive seizures in appropriate patients.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: generalized tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Somnolence: increased sleepiness, especially after dose initiation. - Nausea: occasional upset stomach. - Irritability: mood changes or mild agitation.

Serious or Rare Side Effects: - Severe rash or Stevens‑Johnson syndrome: requires immediate medical attention. - Suicidal thoughts or behavior: monitor for mood changes. - Acute hypersensitivity reactions: including angioedema or anaphylaxis. - Hematologic abnormalities: such as thrombocytopenia or leukopenia.

Before initiating therapy, clinicians should consider several safety factors.

Renal function: assess and adjust dose in patients with impaired clearance. Hepatic function: monitor liver enzymes in patients with liver disease. Psychiatric symptoms: watch for mood swings, depression, or aggression. Driving and operating machinery: advise caution due to possible drowsiness. Pregnancy: safety not established; evaluate risk‑benefit with prescriber. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may significantly reduce levetiracetam plasma concentrations. - Phenobarbital: can lower levetiracetam levels, potentially decreasing seizure control.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression and increase dizziness. - Other antiepileptics (e.g., valproate, phenytoin): may require dose adjustments based on clinical response. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, necessitating additional contraceptive measures.